Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + Behavioral Therapy for Cocaine Use Disorder
NCT03344419Phase 3Suspended
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2017
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in cocaine use disorder (CUD), sponsored by New York State Psychiatric Institute. Started Oct 2017; status: suspended.
02
Drugs
ketamine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT03344419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03344419.